133 related articles for article (PubMed ID: 17716774)
21. Gram-negative pneumonia among patients undergoing dialysis who were admitted to the hospital with angioedema secondary to angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.
Sharma M; Johnson LB
Clin Infect Dis; 2008 Dec; 47(11):1494-5. PubMed ID: 18986269
[No Abstract] [Full Text] [Related]
22. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
Jennings DL; Taber DJ
Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
[TBL] [Abstract][Full Text] [Related]
23. [Hypertension therapy for type 2 diabetics].
Bönner G
MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
[No Abstract] [Full Text] [Related]
24. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate.
McMurray J
BMJ; 2005 May; 330(7502):1269; author reply 1270-1. PubMed ID: 15920134
[No Abstract] [Full Text] [Related]
26. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
27. Taste disturbance by angiotensin-converting enzyme inhibitors/angiotensin-2 receptor blockers.
Ebihara S; Kohzuki M
Kidney Int; 2010 Apr; 77(7):649; author reply 649-50. PubMed ID: 20224593
[No Abstract] [Full Text] [Related]
28. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
[TBL] [Abstract][Full Text] [Related]
29. ACE inhibitors and risk of hypoglycemia in people with diabetes.
Chaturvedi N; Fuller JH
Diabetes Care; 1998 Mar; 21(3):470-2. PubMed ID: 9540046
[No Abstract] [Full Text] [Related]
30. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
32. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
Ku E; Park J; Vidhun J; Campese V
Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
[No Abstract] [Full Text] [Related]
33. Risk of severe hypoglycemia in diabetes patients taking ACE inhibitors.
Strachan MW; Frier BM
Diabetes Care; 1998 Mar; 21(3):470; author reply 471-2. PubMed ID: 9540045
[No Abstract] [Full Text] [Related]
34. Guidelines on the management of valvular heart disease.
Aguiar-Souto P; Mirelis JG; Silva-Melchor L
Eur Heart J; 2007 May; 28(10):1267; author reply 1267-8. PubMed ID: 17463010
[No Abstract] [Full Text] [Related]
35. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
Lonati C; Morganti A
Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
[No Abstract] [Full Text] [Related]
37. Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?
Raja SG; Fida N
Interact Cardiovasc Thorac Surg; 2008 May; 7(3):470-5. PubMed ID: 18272542
[TBL] [Abstract][Full Text] [Related]
38. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
39. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
40. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
Maahs DM; Snell-Bergeon JK; Kinney GL; Wadwa RP; Garg S; Ogden LG; Rewers M
J Diabetes Complications; 2007; 21(5):273-9. PubMed ID: 17825750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]